Avon Launches Fundraiser for ALS TDI
CAMBRIDGE, Mass., Nov. 1, 2011 -- Necklace Named in Honor of Avon Executive Recently Diagnosed with Lou Gehrig's Disease
The ALS Therapy Development Institute (ALS TDI) and the Avon Products, Inc. (Avon) announced today a fundraising campaign to fund research into effective treatments for ALS (Lou Gehrig's disease). The campaign includes the production of a new item called the "Sophia Smith Yellow Rose Necklace" being added to its catalog and with all proceeds going to support research at ALS TDI.
Sophia Smith of Victoria, Texas, started part-time with Avon in 1986 and quickly excelled as a sales Representative, becoming a senior executive and member of the Avon sales leadership team in 1992. She is a mother of three and an avid motorcyclist. In November 2010, Sophia was diagnosed with ALS. Currently, there are no effective treatments or cure for the disease.
"Sophia has always been an inspiring member of the Avon family and it was heartbreaking for all of us to learn of her ALS diagnosis. Tragically, a cure for this debilitating disease may not come in time to help Sophia, but she wants to ensure that others have a fighting chance. We are taking a stand with her and are supporting Sophia through this fundraising campaign," said Andrea Jung, chairman & CEO of Avon.
"With the help of Avon, we hope to build awareness and accelerate the pace of research to find an effective treatment for ALS patients. Sophia is an inspiration, her strength and courage is admired by those around her," said Steve Perrin, Ph.D., president, CEO and CSO of the ALS Therapy Development Institute.
Each necklace costs $9.99 and can be purchased through an Avon Representative or online by clicking "fundraising" at www.avon.com starting today. The necklaces will be available for a limited time only.
About ALS Therapy Development Institute The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the world's largest efforts to preclinically validate potential therapeutics; including a pipeline of dozens of small molecules, protein biologics, gene therapies and cell-based constructs. The world's first nonprofit biotech, ALS TDI has developed an industrial-scale platform that allows for the development and testing of dozens of potential therapeutics each year. Built by and for patients, the Institute is the world's only nonprofit biotechnology company with more than 30 professional scientists. In addition, the Cambridge, Massachusetts based research Institute collaborates with leaders in both academia and industry to accelerate ALS therapeutic development.
More Avon News and Articles
- Avon to Pay Millions to Settle Bribery Charges
- Avon Splits with DSA
- Avon Appoints Pablo Munoz Sr VP and President, North America
- Avon Announces Layoffs
- Avon to Close Two Distribution Facilities
- Avon to Cut 1500 Jobs and Exit 2 Markets
- Avon Announces Makeup Maven Video Contest
- Avon Appoints Chief Marketing Officer
- Avon Reports Disappointing Third Quarter Results
- Avon to Postpone 3Q 2012 Earnings Due To Hurricane
- Avon Executive Chairman to Step Down
- Avon Partners With Paula Abdul On Exclusive Holiday Collection
- Avon Reports Second Quarter 2012 Results
- Avon to Webcast Second Quarter 2012 Earnings Conference Call
- Avon Launches Corporate Responsibility Blog
- Avon Shares Fall 10 Percent After Coty Withdraws Takeover Bid
- Avon Acquisition Proposal Withdrawn by Coty
- Avon Board Considering Coty Buyout Offer
- Coty Raises Offer to Acquire Avon
- Avon Reports First Quarter 2012 Results
- Avon Investors File Lawsuit
- Avon Appoints New CEO
- Avon Products Rejects Buyout Offer from Coty Inc
- Avon Foundation for Women Announces Domestic Violence Grants
- Class Action Lawsuit Filed Against Avon and Mary Kay
- Avon Reports Fourth Quarter and Full Year 2011 Results
- Avon to Webcast 4th Quarter and Full Year Earnings Conference Call
- Avon CEO Steps Down
- Avon Launches Fundraiser for ALS TDI
- Avon Investigated by SEC and Attorneys for Shareholders
- Avon Announces New Anti-Aging Sun Care Product Line
- Jacqueline Bisset Becomes Avon Spokesmodel
- Avon in the New York Times
- Avon Shares Slide on Analyst Downgrades
- Avon Calling Again in New Recruit Drive
- Avon Signs Patrick Dempsey
- Avon Donates 1 Million to UNIFEM Fund
- Avon Introduces Youth Extending Cream
- Avon Shares Rise
- Avon Branches out with Retail Stores
- Avon In Midst of 3 Year Reorganization
- Avon Putting on a Fresh Face
- Avon Stays on Top of MLM Rankings
Avon Profile
Create a Free Avon Rep Listing